☆ 4.8 Letter

Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With High Bleeding Risk Insight From the STOPDAPT-2 Trial

CIRCULATION (2019)

期刊

CIRCULATION

卷 140, 期 23, 页码 1957-1959

出版社

LIPPINCOTT WILLIAMS & WILKINS

DOI: 10.1161/CIRCULATIONAHA.119.043613

关键词

hemorrhage; percutaneous coronary intervention; platelet aggregation inhibitors; stents; thrombosis

类别

Cardiac & Cardiovascular Systems Peripheral Vascular Disease

资金

Abbott Vascular Japan

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Review Cardiac & Cardiovascular Systems

Antiplatelet therapy after percutaneous coronary intervention

Dominick J. Angiolillo, Mattia Galli, Jean-Philippe Collet, Adnan Kastrati, Michelle L. O'Donoghue

Summary: Antiplatelet therapy is crucial for reducing thrombotic complications and ischemic events in patients undergoing percutaneous coronary interventions (PCI), but it is also associated with increased risk of bleeding. Advances in stent technologies and understanding of bleeding risks have led to the development of personalized antiplatelet treatment regimens. Recent research and guidelines have provided several options for antiplatelet therapy after PCI.

EUROINTERVENTION (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Intervention: The HOST-EXAM Extended Study

Jeehoon Kang, Kyung Woo Park, Huijin Lee, Doyeon Hwang, Han-Mo Yang, Seung-Woon Rha, Jang-Whan Bae, Nam Ho Lee, Seung-Ho Hur, Jung-Kyu Han, Eun-Seok Shin, Bon-Kwon Koo, Hyo-Soo Kim

Summary: The HOST-EXAM Extended study investigated the long-term outcomes of antiplatelet monotherapy in patients who underwent percutaneous coronary intervention. It found that clopidogrel monotherapy was associated with lower rates of adverse clinical events compared to aspirin monotherapy in patients without clinical events for 12 ± 6 months after the procedure.

CIRCULATION (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Relationship between platelet aggregation and stroke risk after percutaneous coronary intervention: a PENDULUM analysis

Yuji Matsumaru, Takanari Kitazono, Kazushige Kadota, Koichi Nakao, Yoshihisa Nakagawa, Junya Shite, Hiroyoshi Yokoi, Ken Kozuma, Kengo Tanabe, Takashi Akasaka, Toshiro Shinke, Takafumi Ueno, Atsushi Hirayama, Shiro Uemura, Takeshi Kuroda, Atsushi Takita, Atsushi Harada, Raisuke Iijima, Yoshitaka Murakami, Shigeru Saito, Masato Nakamura

Summary: In patients undergoing percutaneous coronary intervention (PCI) with a stent, high on-treatment platelet reactivity may be associated with an increased risk of stroke. This study found that patients with ischemic stroke within 12-48 hours after PCI had higher platelet reaction unit (PRU) values.

HEART AND VESSELS (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome The HOST-REDUCE-POLYTECH-ACS Trial

Hyo-Soo Kim, Jeehoon Kang, Doyeon Hwang, Jung-Kyu Han, Han-Mo Yang, Hyun-Jae Kang, Bon-Kwon Koo, Seok Yeon Kim, Keun-Ho Park, Seung-Woon Rha, Won-Yong Shin, Hong-Seok Lim, Kyungil Park, Kyung Woo Park

Summary: The study demonstrated that in patients with acute coronary syndrome (ACS), durable polymer drug-eluting stents (DP-DES) were noninferior to biodegradable polymer DES (BP-DES) in terms of patient-oriented composite outcomes at 12 months after percutaneous coronary intervention.

CIRCULATION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Coronary Artery Bypass With Multiarterial Grafting vs Percutaneous Coronary Intervention

Valentino Bianco, Suresh Mulukutla, Edgar Aranda-Michel, Danny Chu, David Kaczorowski, Johannes Bonatti, Pyongsoo Yoon, Dustin Kliner, Catalin Toma, Yisi Wang, Steve Koscumb, Floyd Thoma, Forozan Navid, Derek Serna-Gallegos, Ibrahim Sultan

Summary: This study compares the outcomes of multiarterial grafting and percutaneous coronary intervention (PCI) in patients with multivessel coronary disease. It found that multiarterial grafting is associated with fewer adverse events, improved survival, and reduced hospital readmissions for appropriate patients.

ANNALS OF THORACIC SURGERY (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy

Yaling Han, Bimmer E. Claessen, Shao-Liang Chen, Qiu Chunguang, Yujie Zhou, Yawei Xu, Lin Hailong, Jiyan Chen, Wu Qiang, Ruiyan Zhang, Suxin Luo, Yongjun Li, Jianhua Zhu, Xianxian Zhao, Xiang Cheng, Jian'an Wang, Xi Su, Jianhong Tao, Yingxian Sun, Geng Wang, Yi Li, Liya Bian, Ridhima Goel, Samantha Sartori, Zhongjie Zhang, Dominick J. Angiolillo, David J. Cohen, C. Michael Gibson, Adnan Kastrati, Mitchell Krucoff, Shamir R. Mehta, E. Magnus Ohman, Philippe Gabriel Steg, Yuqi Liu, George Dangas, Samin Sharma, Usman Baber, Roxana Mehran

Summary: The TWILIGHT trial enrolled 1169 patients from China, showing that ticagrelor monotherapy significantly reduced clinically relevant bleeding without increasing ischemic events compared to ticagrelor plus aspirin in Chinese patients undergoing high-risk percutaneous coronary intervention.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Effect of indobufen vs. aspirin on platelet accumulation in patients with stable coronary heart disease after percutaneous coronary intervention: An open-label crossover study

Qiu-Ping Shi, Xing-Yu Luo, Bin Zhang, Xin-Gang Wang, Jing Zhao, Qiu-Fen Xie, Jia-Hui Liu, Yao-Kun Liu, Jie Jiang, Bo Zheng

Summary: This study compared the effect of indobufen and aspirin on platelet function in patients with stable coronary heart disease after percutaneous coronary intervention (PCI). The findings suggest that indobufen has similar antiplatelet effects to aspirin and may be an alternative for patients with aspirin intolerance after coronary stenting.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT

Erin A. Bohula, David D. Berg, Mathew S. Lopes, Jean M. Connors, Ijlal Babar, Christopher F. Barnett, Sunit-Preet Chaudhry, Amit Chopra, Wilson Ginete, Michael H. Ieong, Jason N. Katz, Edy Y. Kim, Julia F. Kuder, Emilio Mazza, Dalton McLean, Jarrod M. Mosier, Ari Moskowitz, Sabina A. Murphy, Michelle L. O'Donoghue, Jeong-Gun Park, Rajnish Prasad, Christian T. Ruff, Mohamad N. Shahrour, Shashank S. Sinha, Stephen D. Wiviott, Sean Van Diepen, Mark Zainea, Vivian Baird-Zars, Marc S. Sabatine, David A. Morrow

Summary: The study evaluated the efficacy and safety of prophylactic full-dose anticoagulation and antiplatelet therapy in critically ill COVID-19 patients. The results showed that full-dose anticoagulation can reduce the risk of thrombotic complications, but increases the risk of bleeding.

CIRCULATION (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Role of platelet function and genetic testing in patients undergoing percutaneous coronary intervention

Mattia Galli, Francesco Franchi, Fabiana Rollini, Dominick J. Angiolillo

Summary: Dual antiplatelet therapy (DAPT) is the standard treatment for patients undergoing percutaneous coronary intervention (PCI). However, using a standard DAPT regimen for all patients could result in suboptimal efficacy or high bleeding risk for certain individuals. Guided selection of P2Y12 inhibitors based on platelet function or genetic testing has shown promising results in achieving a better balance between bleeding and ischemic events at the individual patient level. This review focuses on the rationale and evidence for platelet function and genetic testing-guided antiplatelet therapy and explores their implications in the modern setting of patients undergoing PCI.

TRENDS IN CARDIOVASCULAR MEDICINE (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention

Seung Hun Lee, Hyun Kuk Kim, Myung Ho Jeong, Satoshi Yasuda, Satoshi Honda, Young-Hoon Jeong, Joo Myung Lee, Joo-Yong Hahn, Jeehoon Kang, Shung Chull Chae, In-Whan Seong, Jong-Seon Park, Jei Keon Chae, Seung-Ho Hur, Kwang Soo Cha, Hyo-Soo Kim, Ki-Bae Seung, Seung-Woon Rha, Jin-Yong Hwang, Dong-Ju Choi, Seok Kyu Oh, Sung Soo Kim, Taek Kyu Park, Jeong Hoon Yang, Young Bin Song, Seung-Hyuk Choi, Hyeon-Cheol Gwon

Summary: The study developed a new risk scoring system to guide the selection of potent P2Y12 inhibitors for dual antiplatelet therapy, balancing ischaemic benefit and bleeding risk.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)

添加到收藏夹

Article Clinical Neurology

Timing and Spectrum of Neurological Complications After Flow Diverter Implantation for Intracranial Aneurysms

Guillaume Charbonnier, Jean-Philippe Desilles, Simon Escalard, Benjamin Maier, Gabriele Ciccio, Stanislas Smajda, Robert Fahed, Francois Delvoye, Hocine Redjem, Raphael Blanc, Michel Piotin, Mikael Mazighi

Summary: Neurological complications after FD implantation were mainly caused by cerebrovascular ischemic events during the peri-operative period, but could also occur in a delayed manner after 1 year. Long-term follow-up is important after aneurysm intervention using FD.

FRONTIERS IN NEUROLOGY (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention JACC Review Topic of the Week

Alexander E. Sullivan, Michael G. Nanna, Tracy Y. Wang, Deepak L. Bhatt, Dominick J. Angiolillo, Roxana Mehran, Subhash Banerjee, Sarah Cantrell, W. Schuyler Jones, Jennifer A. Rymer, Jeffrey B. Washam, Sunil V. Rao, E. Magnus Ohman

Summary: Patients undergoing early surgery after coronary stent implantation face increased mortality risk from ischemic and hemorrhagic complications. The optimal antiplatelet strategy for patients who cannot discontinue dual antiplatelet therapy before surgery remains unclear. Current guidelines provide risk stratification for bridging therapy with intravenous antiplatelet agents, but management is primarily guided by expert opinion in the absence of randomized controlled data.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

添加到收藏夹

Article Cell Biology

Association of lipoprotein(a) with platelet aggregation and thrombogenicity in patients undergoing percutaneous coronary intervention

Pei Zhu, Xiao-Fang Tang, Ying Song, Yin Zhang, Li-Jian Gao, Zhan Gao, Jue Chen, Yue-Jin Yang, Run-Lin Gao, Bo Xu, Jin-Qing Yuan

Summary: This study found that patients with higher lipoprotein(a) levels had increased platelet aggregation and thrombogenicity during PCI, leading to a higher risk of ischemic events.

PLATELETS (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors - a VALIDATE-SWEDEHEART Substudy

Sofia Bergman, Moman A. Mohammad, Stefan K. James, Oskar Angeras, Henrik Wagner, Jens Jensen, Fredrik Schersten, Ole Frobert, Sasha Koul, David Erlinge

Summary: IPST is a rare but dangerous complication during percutaneous coronary intervention, independently associated with poor prognosis, including cardiovascular death, target vessel revascularization, and definite stent thrombosis. Future treatment studies are needed to reduce the rate of IPST.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

A new function for MAP4K4 inhibitors during platelet aggregation and platelet-mediated clot retraction

Gi Suk Nam, Soyoung Kim, Yun-Suk Kwon, Min-Kyung Kim, Kyung-Soo Nam

Summary: MAP4K4 inhibitors reduce thrombus formation by regulating platelet activation, showing potential for the treatment of thrombosis.

BIOCHEMICAL PHARMACOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan-From the CREDO-Kyoto Registry Cohort-2 and Cohort-3

Masahiro Natsuaki, Takeshi Morimoto, Hiroki Shiomi, Ko Yamamoto, Kyohei Yamaji, Hirotoshi Watanabe, Takashi Uegaito, Mitsuo Matsuda, Toshihiro Tamura, Ryoji Taniguchi, Moriaki Inoko, Hiroshi Mabuchi, Teruki Takeda, Takenori Domei, Manabu Shirotani, Natsuhiko Ehara, Hiroshi Eizawa, Katsuhisa Ishii, Masaru Tanaka, Tsukasa Inada, Tomoya Onodera, Ryuzo Nawada, Eiji Shinoda, Miho Yamada, Takashi Yamamoto, Hiroshi Sakai, Mamoru Toyofuku, Takashi Tamura, Mamoru Takahashi, Tomohisa Tada, Hiroki Sakamoto, Takeshi Tada, Kazuhisa Kaneda, Shinji Miki, Takeshi Aoyama, Satoru Suwa, Yukihito Sato, Kenji Ando, Yutaka Furukawa, Yoshihisa Nakagawa, Kazushige Kadota, Takeshi Kimura

Summary: Radiofrequency ablation is a method of treating arrhythmias by delivering high-frequency electrical current through a catheter into the heart to disrupt heart tissue. It is commonly used to treat conditions such as atrial fibrillation.

CIRCULATION JOURNAL (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Ischemic and Bleeding Events After First Major Bleeding Event in Patients Undergoing Coronary Stent Implantation

Ko Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, Hiroki Shiomi, Yusuke Yoshikawa, Junichi Tazaki, Takeshi Tada, Hirotoshi Watanabe, Eri Kato, Mamoru Toyofuku, Tsukasa Inada, Kazuhisa Kaneda, Teruki Takeda, Hiroshi Sakai, Takashi Yamamoto, Hiroshi Eizawa, Miho Yamada, Eiji Shinoda, Hiroshi Mabuchi, Manabu Shirotani, Mitsuo Matsuda, Mamoru Takahashi, Katsuhisa Ishii, Tomoya Onodera, Hiroki Sakamoto, Takeshi Aoyama, Shinji Miki, Kenji Ando, Takeshi Kimura

Summary: There is a lack of data on ischemic and bleeding events in patients who experienced major bleeding after PCI, and the incidence of these events after major bleeding is higher and associated with increased mortality.

AMERICAN JOURNAL OF CARDIOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Coronary Artery Disease Without Standard Cardiovascular Risk Factors

Ko Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, Hiroki Shiomi, Yasuaki Takeji, Kyohei Yamaji, Yukiko Matsumura-Nakano, Yusuke Yoshikawa, Erika Yamamoto, Masayuki Fuki, Eri Kato, Yugo Yamashita, Hidenori Yaku, Kenji Nakatsuma, Hiroki Watanabe, Mitsuo Matsuda, Toshihiro Tamura, Moriaki Inoko, Hiroshi Mabuchi, Manabu Shirotani, Hiroshi Eizawa, Katsuhisa Ishii, Tsukasa Inada, Tomoya Onodera, Eiji Shinoda, Takashi Yamamoto, Mamoru Toyofuku, Mamoru Takahashi, Hiroki Sakamoto, Shinji Miki, Takeshi Aoyama, Satoru Suwa, Yukihito Sato, Yutaka Furukawa, Kenji Ando, Kazushige Kadota, Yoshihisa Nakagawa, Takeshi Kimura

Summary: A recent observational study found that patients without standard cardiovascular risk factors had higher mortality rates compared to those with risk factors. Patients with risk factors were more likely to have a history of atherosclerotic disease and receive optimal medical therapy.

AMERICAN JOURNAL OF CARDIOLOGY (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

JCS/JSCVS 2018 Guideline on Revascularization of Stable Coronary Artery Disease

Masato Nakamura, Hitoshi Yaku, Junya Ako, Hirokuni Arai, Tohru Asai, Taishiro Chikamori, Hiroyuki Daida, Kiyoshi Doi, Toshihiro Fukui, Toshiaki Ito, Kazushige Kadota, Junjiro Kobayashi, Tatsuhiko Komiya, Ken Kozuma, Yoshihisa Nakagawa, Koichi Nakao, Hiroshi Niinami, Takayuki Ohno, Yukio Ozaki, Masataka Sata, Shuichiro Takanashi, Hirofumi Takemura, Takafumi Ueno, Satoshi Yasuda, Hitoshi Yokoyama, Tomoyuki Fujita, Tokuo Kasai, Shun Kohsaka, Takashi Kubo, Susumu Manabe, Naoya Matsumoto, Shigeru Miyagawa, Tomohiro Mizuno, Noboru Motomura, Satoshi Numata, Hiroyuki Nakajima, Hirotaka Oda, Hiromasa Otake, Fumiyuki Otsuka, Ken-Ichiro Sasaki, Kazunori Shimada, Tomoki Shimokawa, Toshiro Shinke, Tomoaki Suzuki, Masao Takahashi, Nobuhiro Tanaka, Hiroshi Tsuneyoshi, Taiki Tojo, Dai Une, Satoru Wakasa, Koji Yamaguchi, Takashi Akasaka, Atsushi Hirayama, Kazuo Kimura, Takeshi Kimura, Yoshiro Matsui, Shunichi Miyazaki, Yoshitaka Okamura, Minoru Ono, Hiroki Shiomi, Kazuo Tanemoto

CIRCULATION JOURNAL (2022)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Paradigm Shift in Ischemia Evaluation and Accumulating Evidence of Safety of Deferred Coronary Revascularization on the Basis of Invasive Fractional Flow Reserve Measurement

Hiroki Shiomi

CIRCULATION JOURNAL (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Caregiver experience with decision-making difficulties in end-of-life care for patients with cardiovascular diseases

Keitaro Shinada, Takashi Kohno, Keiichi Fukuda, Michiaki Higashitani, Naoto Kawamatsu, Takeshi Kitai, Tatsuhiro Shibata, Makoto Takei, Kotaro Nochioka, Gaku Nakazawa, Hiroki Shiomi, Mitsunori Miyashita, Atsushi Mizuno

Summary: Approximately 30% of bereaved caregivers experience decisional burdens during end-of-life care for cardiovascular disease patients, and these difficulties are associated with patient, caregiver, and physician factors as well as subsequent psychological distress.

JOURNAL OF CARDIOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Clopidogrel Monotherapy After 1-Month Dual Anti platelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort

Yuki Obayashi, Hirotoshi Watanabe, Takeshi Morimoto, Ko Yamamoto, Masahiro Natsuaki, Takenori Domei, Kyohei Yamaji, Satoru Suwa, Tsuyoshi Isawa, Hiroki Watanabe, Ruka Yoshida, Hiroki Sakamoto, Masaharu Akao, Yoshiki Hata, Itsuro Morishima, Hideo Tokuyama, Masahiro Yagi, Hiroshi Suzuki, Kohei Wakabayashi, Nobuhiro Suematsu, Tsukasa Inada, Toshihiro Tamura, Hideki Okayama, Mitsuru Abe, Kazuya Kawai, Koichi Nakao, Kenji Ando, Kengo Tanabe, Yuji Ikari, Yoshihiro Morino, Kazushige Kadota, Yutaka Furukawa, Yoshihisa Nakagawa, Takeshi Kimura

Summary: In this study, clopidogrel monotherapy after 1-month dual antiplatelet therapy was found to reduce major bleeding events without increasing cardiovascular events compared to 12-month dual antiplatelet therapy with aspirin and clopidogrel.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

P2Y(12) inhibitor monotherapy in patients undergoing percutaneous coronary intervention

Davide Capodanno, Usman Baber, Deepak L. Bhatt, Jean-Philippe Collet, George Dangas, Francesco Franchi, C. Michael Gibson, Hyeon-Cheol Gwon, Adnan Kastrati, Takeshi Kimura, Pedro A. Lemos, Renato D. Lopes, Roxana Mehran, Michelle L. O'Donoghue, Sunil Rao, Fabiana Rollini, Patrick W. Serruys, Philippe G. Steg, Robert F. Storey, Marco Valgimigli, Pascal Vranckx, Hirotoshi Watanabe, Stephan Windecker, Dominick J. Angiolillo

Summary: The evolution of stent design has reduced the risk of stent thrombosis after PCI, potentially shortening the duration of dual antiplatelet therapy. Recent studies suggest that P2Y(12) inhibitor monotherapy after PCI may be safer and more effective than dual antiplatelet therapy.

NATURE REVIEWS CARDIOLOGY (2022)

添加到收藏夹

Article Surgery

Acute coronary syndrome after liver transplantation in a young primary biliary cholangitis recipient with dyslipidemia: a case report

Siyuan Yao, Akiho Iwashita, Shintaro Yagi, Hirotoshi Watanabe, Takahiro Nishio, Yukinori Koyama, Kazuyuki Nagai, Naoko Kamo, Kojiro Taura, Etsuro Hatano

Summary: PBC-related dyslipidemia potentially increases the risk of developing ACS after liver transplantation, suggesting the need for preoperative evaluation of the coronary artery, particularly in high-risk patients with drug-resistant dyslipidemia.

SURGICAL CASE REPORTS (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention

Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, Akiyoshi Miyazawa, Hiroki Watanabe, Masahiro Natsuaki, Hirotoshi Watanabe, Kyohei Yamaji, Masanobu Ohya, Sunao Nakamura, Satoru Mitomo, Satoru Suwa, Takenori Domei, Shojiro Tatsushima, Koh Ono, Hiroki Sakamoto, Kiyotaka Shimamura, Masataka Shigetoshi, Ryoji Taniguchi, Yuji Nishimoto, Hideki Okayama, Kensho Matsuda, Takafumi Yokomatsu, Masahiro Muto, Ren Kawaguchi, Koichi Kishi, Mitsuyoshi Hadase, Tsutomu Fujita, Yasunori Nishida, Masami Nishino, Hiromasa Otake, Nobuhiro Suematsu, Tsuneki Ajimi, Kengo Tanabe, Mitsuru Abe, Kiyoshi Hibi, Kazushige Kadota, Kenji Ando, Takeshi Kimura

Summary: This study evaluated the association between various stent expansion criteria and target lesion revascularization (TLR) after intravascular ultrasound-guided percutaneous coronary intervention (PCI) and found that minimum stent area (MSA) and calcified lesions were associated with TLR, while other stent expansion criteria were not.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Post-contrast Acute Kidney Injury After Emergent and Elective Percutaneous Coronary Intervention (from the CREDO-Kyoto PCI/CABG Registry Cohort 3)

Kazuhisa Kaneda, Hiroki Shiomi, Mitsuru Abe, Takeshi Morimoto, Ko Yamamoto, Yuki Obayashi, Ryusuke Nishikawa, Akinori Tamura, Kazushige Kadota, Takenori Domei, Kenji Nakatsuma, Takafumi Yokomatsu, Masao Imai, Tomohiko Taniguchi, Ryuzo Nawada, Mamoru Toyofuku, Toshihiro Tamura, Tsukasa Inada, Mitsuo Matsuda, Yukihito Sato, Yutaka Furukawa, Kenji Ando, Yoshihisa Nakagawa, Takeshi Kimura

Summary: Post-contrast acute kidney injury (PC-AKI) is a common complication after percutaneous coronary intervention (PCI), and its impact on long-term clinical outcomes may differ between emergent and elective procedures.

AMERICAN JOURNAL OF CARDIOLOGY (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The Impact of Mitral Regurgitation on Long-Term Outcomes in Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Yuki Obayashi, Hiroki Shiomi, Takeshi Morimoto, Makoto Miyake, Moriaki Inoko, Ryusuke Nishikawa, Kazuhisa Kaneda, Ko Yamamoto, Yasuaki Takeji, Tomohisa Tada, Kazuya Nagao, Takashi Uegaito, Natsuhiko Ehara, Hiroshi Sakai, Satoru Suwa, Toshihiro Tamura, Hiroki Sakamoto, Tsukasa Inada, Mitsuo Matsuda, Yukihito Sato, Yutaka Furukawa, Kenji Ando, Kazushige Kadota, Yoshihisa Nakagawa, Takeshi Kimura

Summary: This study aimed to clarify the precise impact of mitral regurgitation (MR) on long-term outcomes in acute myocardial infarction (AMI) patients who underwent percutaneous coronary intervention (PCI). The results showed that the severity of MR was closely related to the incidence of all-cause death, cardiovascular death, and hospitalization for heart failure (HF), but after adjusting for confounders, only hospitalization for HF was independently associated with MR.

AMERICAN JOURNAL OF CARDIOLOGY (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Ten-year clinical outcomes from a randomized trial comparing new-generation everolimus-eluting stent versus first-generation Sirolimus-eluting stent: Results from the RESET extended study

Hiroki Shiomi, Ken Kozuma, Takeshi Morimoto, Kazushige Kadota, Kengo Tanabe, Yoshihiro Morino, Toshihiro Tamura, Mitsuru Abe, Satoru Suwa, Yoshiaki Ito, Masakazu Kobayashi, Kazuoki Dai, Koichi Nakao, Yasuhiro Tarutani, Ryoji Taniguchi, Hideo Nishikawa, Yoshito Yamamoto, Tomohiro Yamasaki, Atsunori Okamura, Yoshihisa Nakagawa, Kenji Ando, Koichi Kobayashi, Kazuya Kawai, Kiyoshi Hibi, Takeshi Kimura, RESET Investigators

Summary: This study compared the 10-year clinical outcomes of new-generation drug-eluting stents (DES) and first-generation DES, and found no significant differences in primary efficacy and safety endpoints. However, the new-generation stents had a lower risk for composite endpoints.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2023)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Response by Yamamoto et al to Letter Regarding Article, Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention

Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, Takeshi Kimura

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.